People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rejuvitas, Inc. | — | Biotechnology | Series A | $8.3M | $63.5M | 2021 |
| ProJenX, Inc. | — | Biotechnology | Series A | $5.1M | $90.4M | 2021 |
Joni Mancini at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joni Mancini on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eric Heil | 2 | 5 |
| John Prufeta | 2 | 3 |
| Andrea Spezzi | 1 | 1 |
| Hynek Wichterle | 1 | 1 |
| Valerie Estess | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.